| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Chief Operating Officer
1 company
Tessari Eben is a Chief Operating Officer at Kiniksa Pharmaceuticals International, plc. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $949K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 14, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE | 18,900 | $28.72 | $542,808.00 | -27.8% | +28.6% | - | |
| Jun 16, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE | 17,300 | $28.28 | $489,244.00 | -21.9% | +28.7% | - | |
| Jun 11, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE | 70,867 | $30.48 | $2,160,035.40 | -24.6% | +22.0% | - | |
| May 19, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE | 12,000 | $26.41 | $316,920.00 | -14.2% | +26.1% | - | |
| Apr 14, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE | 12,000 | $20.48 | $245,811.55 | -6.9% | +39.2% | +127.5% | |
| Mar 10, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE | 12,409 | $21.06 | $261,333.54 | -13.9% | +45.4% | +125.4% | |
| Feb 10, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE | 14,000 | $19.57 | $273,980.00 | -14.6% | +36.9% | +128.1% | |
| Jan 13, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE | 14,000 | $18.24 | $255,413.15 | -7.2% | +13.9% | +112.4% | |
| Dec 16, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE | 23,017 | $20.44 | $470,467.48 | -19.3% | +13.0% | +103.6% | |
| Nov 18, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE | 17,000 | $21.04 | $357,680.00 | -14.2% | -9.1% | +92.0% |